top of page
external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus. 
Explore the latest updates from the life science industry.

Popular Content.

BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

Aiming to Redefine the Data Foundations of AI-Driven Drug Discovery, the landmark initiative partners with Anthropic, Ultima Genomics, PacBio and NVIDIA to generate and model biological data at an unprecedented scale.

 Featured Articles. 

7-format11240.jpg
PHARMA

Inside Nxera Pharma’s Next-Generation Biopharma Model

7-format11240.jpg
BIOTECH

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

7-format11240.jpg
HEALTH

Killing Mosquitoes With the Smell of Flowers

7-format11240.jpg
BIOTECH

Antiverse Targets Drug Discovery's "Undruggable" Frontier with AI-Driven Antibodies

7-format11240.jpg
BIOPROCESSING

FUJIFILM Biotechnologies Launches UK’s Largest Single-Use Biomanufacturing Facility

7-format11240.jpg
BIOTECH

First Human Egg 'Rejuvenation' Offers Hope for Older IVF Patients

7-format11240.jpg
SUSTAINABILITY

Engineering Crops From the Inside Out

7-format11240.jpg
BIOTECH

Free Lab Software Aims to Ease the Data Management Burden for Academic Researchers

7-format11240.jpg
HEALTH

Sanome Partners With NHS Trusts to Deploy AI-Powered Clinical Intelligence for Earlier Infection Detection

 Latest News. 

3rd April, 2026

01.

PRISM ALS Sets Out to Improve ALS/MND Drug Discovery

A new international collaboration is building more representative stem cell models of ALS, an effort that could improve drug discovery and reduce clinical trial failure rates.

22nd March, 2026

02.

Basecamp Research Launches the Trillion Gene Atlas

Aiming to Redefine the Data Foundations of AI-Driven Drug Discovery, the landmark initiative partners with Anthropic, Ultima Genomics, PacBio and NVIDIA to generate and model biological data at an unprecedented scale.

20th March, 2026

03.

Inside Nxera Pharma’s Next-Generation Biopharma Model

From AI-enabled GPCR discovery to partnership-driven growth, Nxera is redefining how medicines are built and commercialised.

19th March, 2026

04.

ProImmune and Roslin Institute Partner to Expand Tools for Veterinary Immunology

Collaboration aims to develop species-specific binders to accelerate research and improve control of zoonotic diseases.

Editor's Selects.

Weighing the Cost of Semaglutide

First Human Egg ‘Rejuvenation’ Offers Hope for Older IVF Patients

A Simple Pad Could Transform Cervical Cancer Screening

Inside Nxera Pharma’s Next-Generation Biopharma Model

Stay up-to-date. Connect with BioFocus on LinkedIn or subscribe to our mailing list.

bottom of page